COX-2 Inhibitors at The 8th International Conference of the Inflammation Research Association

By Parnham M.J.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 1, 1997-01 ,pp. : 79-83

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs

By Santing R.E.   Olymulder C.G.   Van der Molen K.   Meurs H.   Zaagsma J.  

European Journal of Pharmacology, Vol. 275, Iss. 1, 1995-02 ,pp. : 75-82

Elsevier

Access to resources Recommend Favorite

Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors

By de Gaetano G.   Donati M.B.   Cerletti C.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 5, 2003-05 ,pp. : 245-252

Elsevier

Access to resources Recommend Favorite

COX-2 inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 9, 2003-09 ,pp. : 1465-1468

Informa Healthcare

Access to resources Recommend Favorite

Dual COX-Inhibitors: The Answer is NO?

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 5, 2005-06 ,pp. : 487-492

Bentham Science Publishers

Access to resources Recommend Favorite